elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33390438-8B0B812C-749A-4F95-858F-71B52057D1AC
Q33390438-8B0B812C-749A-4F95-858F-71B52057D1AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33390438-8B0B812C-749A-4F95-858F-71B52057D1AC
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
P6179
Q33390438-8B0B812C-749A-4F95-858F-71B52057D1AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33390438-8B0B812C-749A-4F95-858F-71B52057D1AC
rank
NormalRank
type
BestRank
Statement
P6179
1031492889
http://www.w3.org/2001/XMLSchema#string